Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.790
+0.030 (1.70%)
Jun 4, 2026, 4:00 PM EDT - Market closed
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $169.51 million as of June 4, 2026. Its market cap has decreased by -15.49% in one year.
Market Cap
169.51M
Enterprise Value
155.86M
1-Year Change
-15.49%
Ranking
Category
Stock Price
$1.79
Market Cap Chart
Since April 25, 2013, Innate Pharma's market cap has increased from $125.22M to $169.51M, an increase of 35.37%. That is a compound annual growth rate of 2.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 169.51M | -2.24% |
| Dec 31, 2025 | 173.38M | 4.71% |
| Dec 31, 2024 | 165.58M | -29.08% |
| Dec 29, 2023 | 233.49M | -17.19% |
| Dec 30, 2022 | 281.97M | -29.50% |
| Dec 31, 2021 | 399.94M | 19.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Milestone Pharmaceuticals | 177.55M |
| MediWound | 174.66M |
| Tenaya Therapeutics | 173.60M |
| Acumen Pharmaceuticals | 173.35M |
| OnKure Therapeutics | 169.66M |
| Galectin Therapeutics | 163.98M |
| Spero Therapeutics | 162.70M |
| Precision BioSciences | 162.55M |